A Review on the Drugs Approved by US-FDA and DCGI

TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
doi 10.21522/tijcr.2014.03.01.art028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Texila Educational And Management Services

Related search

Quantitative Analysis on the Characteristics of Targets With FDA Approved Drugs

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2008English

Drug Development Process and Novel Drugs Approved by FDA for 2017 -18

Applied Clinical Research, Clinical Trials and Regulatory Affairs
2018English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Patient-Reported Outcomes in Orphan Drug Labels Approved by the US FDA

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Possible FDA-approved Drugs to Treat Ebola Virus Infection

Infectious Diseases of Poverty
MedicineEnvironmentalPublic HealthInfectious DiseasesOccupational Health
2015English

Analysis of the Ultra-Orphan Drugs Approved by the Fda in the Period 1983-2014

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Identification of FDA-approved Drugs That Computationally Bind to MDM2

Chemical Biology and Drug Design
BiochemistryOrganic ChemistryDrug DiscoveryMolecular MedicinePharmacology
2012English

Identification of FDA Approved Drugs Targeting COVID-19 Virus by Structure-Based Drug Repositioning

2020English

New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy